"/> Novus Biologicals™ Peptide bloquant d’anticorps CM… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps CMYA5

Réf. : BL-RE-051290Réf. fabricant : 18290456 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
202333
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77117. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 18 amino acids near the carboxy terminus of human SPRYD2.

Points forts

Source

Synthetic

(Accession #: NP_705838) The CMYA5 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-051290
Réf. fabricant18290456
Gene ID (Entrez)202333
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77117. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneC5orf10, cardiomyopathy associated 5, cardiomyopathy-associated protein 5, DKFZp451G182, DKFZp451G223, DTNBP2, dystrobrevin-binding protein 2, genethonin-3, myospryn, SPRY domain-containing protein 2, SPRYD2, tripartite motif-containing protein 76
Symbole de gène(s)CMYA5
Type de produitCMYA5
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne18 amino acids near the carboxy terminus of human SPRYD2
Une question, une configuration particulière ?
Contactez-nous pour un devis.